Ylä-Herttuala S - Search Results

1

Clinical trials for glioblastoma multiforme using adenoviral vectors.

Wirth T, Samaranayake H, Pikkarainen J, Määttä AM, Ylä-Herttuala S. Wirth T, et al. Curr Opin Mol Ther. 2009 Oct;11(5):485-92. Curr Opin Mol Ther. 2009. PMID: 19806496 Review.

2

Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo.

Koponen JK, Kankkonen H, Kannasto J, Wirth T, Hillen W, Bujard H, Ylä-Herttuala S. Koponen JK, et al. Gene Ther. 2003 Mar;10(6):459-66. doi: 10.1038/sj.gt.3301889. Gene Ther. 2003. PMID: 12621450

3

Angiogenesis clinical trials.

Ylä-Herttuala S. Ylä-Herttuala S. Ernst Schering Res Found Workshop. 2003;(43):19-23. doi: 10.1007/978-3-662-05352-2_2. Ernst Schering Res Found Workshop. 2003. PMID: 12894448 Review. No abstract available.

4

Targeting of biotinylated compounds to its target tissue using a low-density lipoprotein receptor-avidin fusion protein.

Lehtolainen P, Wirth T, Taskinen AK, Lehenkari P, Leppänen O, Lappalainen M, Pulkkanen K, Marttila A, Marjomäki V, Airenne KJ, Horton M, Kulomaa MS, Ylä-Herttuala S. Lehtolainen P, et al. Gene Ther. 2003 Dec;10(25):2090-7. doi: 10.1038/sj.gt.3302120. Gene Ther. 2003. PMID: 14595382

5

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.

Immonen A, Vapalahti M, Tyynelä K, Hurskainen H, Sandmair A, Vanninen R, Langford G, Murray N, Ylä-Herttuala S. Immonen A, et al. Mol Ther. 2004 Nov;10(5):967-72. doi: 10.1016/j.ymthe.2004.08.002. Mol Ther. 2004. PMID: 15509514 Free article. Clinical Trial.

6

A multipurpose vector system for the screening of libraries in bacteria, insect and mammalian cells and expression in vivo.

Laitinen OH, Airenne KJ, Hytönen VP, Peltomaa E, Mähönen AJ, Wirth T, Lind MM, Mäkelä KA, Toivanen PI, Schenkwein D, Heikura T, Nordlund HR, Kulomaa MS, Ylä-Herttuala S. Laitinen OH, et al. Nucleic Acids Res. 2005 Feb 24;33(4):e42. doi: 10.1093/nar/gni042. Nucleic Acids Res. 2005. PMID: 15731335 Free PMC article.

7

Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression.

Dworakowska D, Jassem E, Jassem J, Karmoliński A, Dworakowski R, Wirth T, Gruchała M, Rynkiewicz A, Skokowski J, Yla-Herttuala S, Jaśkiewicz K, Czestochowska E. Dworakowska D, et al. J Cancer Res Clin Oncol. 2005 Sep;131(9):617-23. doi: 10.1007/s00432-005-0010-7. Epub 2005 Oct 20. J Cancer Res Clin Oncol. 2005. PMID: 16028106

8

Gene therapy for malignant glioma: current clinical status.

Pulkkanen KJ, Yla-Herttuala S. Pulkkanen KJ, et al. Mol Ther. 2005 Oct;12(4):585-98. doi: 10.1016/j.ymthe.2005.07.357. Mol Ther. 2005. PMID: 16095972 Free article. Review.

9

Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo.

Kaikkonen MU, Räty JK, Airenne KJ, Wirth T, Heikura T, Ylä-Herttuala S. Kaikkonen MU, et al. Gene Ther. 2006 Feb;13(4):304-12. doi: 10.1038/sj.gt.3302657. Gene Ther. 2006. PMID: 16267571

10

Gene technology based therapies in the brain.

Wirth T, Ylä-Herttuala S. Wirth T, et al. Adv Tech Stand Neurosurg. 2006;31:3-32. doi: 10.1007/3-211-32234-5_1. Adv Tech Stand Neurosurg. 2006. PMID: 16768302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters